Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,782 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of long-term clinical outcomes of CHOP chemotherapy between Japanese patients with nodal peripheral T-cell lymphomas and those with diffuse large B-cell lymphoma in the study group of the Tohoku Hematology Forum.
Akagi T, Takahashi N, Yamaguchi K, Ishizawa K, Murai K, Tajima K, Ikeda K, Kameoka Y, Kameoka J, Ito S, Kato Y, Noji H, Shichishima T, Itoh J, Ichinohasama R, Harigae H, Ishida Y, Sawada K. Akagi T, et al. Among authors: sawada k. J Clin Exp Hematop. 2011;51(1):29-35. doi: 10.3960/jslrt.51.29. J Clin Exp Hematop. 2011. PMID: 21628858 Free article.
T-cell prolymphocytic leukemia in Japan: is it a variant?
Kameoka J, Takahashi N, Noji H, Murai K, Tajima K, Kameoka Y, Sato S, Shichishima T, Ishida Y, Harigae H, Sawada K. Kameoka J, et al. Among authors: sawada k. Int J Hematol. 2012 Jun;95(6):660-7. doi: 10.1007/s12185-012-1077-y. Epub 2012 Apr 24. Int J Hematol. 2012. PMID: 22527853
Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma.
Kameoka Y, Takahashi N, Ishizawa K, Kato Y, Ito J, Sasaki O, Murai K, Noji H, Hirokawa M, Tajima K, Shichishima T, Ishida Y, Harigae H, Sawada K. Kameoka Y, et al. Among authors: sawada k. Int J Hematol. 2012 Nov;96(5):624-30. doi: 10.1007/s12185-012-1186-7. Epub 2012 Oct 1. Int J Hematol. 2012. PMID: 23054649 Clinical Trial.
Delayed addition of tumor necrosis factor (TNF) antagonists inhibits the generation of CD11c+ dendritic cells derived from CD34+ cells exposed to TNF-alpha.
Guo YM, Hirokawa M, Takahashi N, Fujishima M, Fujishima N, Komatsuda A, Tagawa H, Ohyagi H, Michishita Y, Ubukawa K, Hebiguchi M, Xiao W, Sawada K. Guo YM, et al. Among authors: sawada k. Int J Hematol. 2010 Jan;91(1):61-8. doi: 10.1007/s12185-009-0456-5. Epub 2009 Dec 12. Int J Hematol. 2010. PMID: 20012512
1,782 results